Osteofrac 750mcg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Teriparatide (750mcg)
Overview Osteofrac 750mcg Injection
Parathyroid hormone therapy, such as Osteofrac 750mcg Injection, is prescribed for men and postmenopausal women with severe osteoporosis facing a heightened fracture risk. This synthetic hormone promotes bone regeneration, leading to increased bone density and a reduced risk of vertebral fractures. Administered subcutaneously or by a medical professional, Osteofrac 750mcg requires consistent daily dosing for optimal efficacy. Treatment typically lasts up to two years, though adherence to the physician's prescribed course is essential regardless of symptom improvement. Refrigeration between 2°C and 8°C is crucial for proper storage. While common side effects may include arthralgia, injection site inflammation (pain, edema, erythema), and lower limb spasms, persistent or bothersome symptoms warrant medical attention. Prior to commencing treatment, disclose any kidney issues, including nephrolithiasis, as hypercalcemia may occur. Pregnant or lactating individuals should seek medical counsel before use. Regular bone density assessments may be recommended to monitor therapeutic progress.
Uses of Osteofrac 750mcg Injection
Bone fragility
Major Benefits of Osteofrac 750mcg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Osteofrac 750mcg Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Osteofrac 750mcg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Osteofrac 750mcg Injection works:
Osteofrac 750mcg Injection, a synthetic parathyroid hormone (PTH) analog, stimulates bone formation by enhancing osteoblast activity and population. This leads to increased bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Osteofrac 750mcg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Osteofrac 750mcg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Osteofrac 750mcg Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
The 750mcg Osteofrac injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
For individuals with kidney impairment, administering Osteofrac 750mcg Injection requires careful consideration. A modified dosage of Osteofrac 750mcg Injection might be necessary. Physician consultation is advised. Osteofrac 750mcg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Osteofrac 750mcg Injection use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Osteofrac 750mcg Injection :
Should you forget a dose of Osteofrac 750mcg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Osteofrac 750mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-Related Peptides |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
3,018 People bought this recently